BILIVERDIN REDUCTASE A IN BRAIN INSULIN SIGNALING AND OXIDATIVE STRESS MEDIATED...
BILIVERDIN REDUCTASE A IN BRAIN INSULIN SIGNALING AND OXIDATIVE STRESS MEDIATED NEURODEGENERATION
Alzheimer disease (AD) is the most common form of dementia among the elderly, whose care in Europe demands an amount of financial resources which is rising dramatically making AD a financial problem. Delaying AD onset by 5 years w...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2008-00011
ANALISIS DE LA VIA DE SEÑALIZACION INSULINA/IRS-2 COMO UN LI...
182K€
Cerrado
MITOABETA
Investigation of Beta Amyloid Peptide Effects On Mitochondri...
167K€
Cerrado
PSI2017-84290-R
PREVENCION Y TRATAMIENTO DEL DECLIVE COGNITIVO ASOCIADO AL E...
70K€
Cerrado
RTI2018-095793-B-I00
INTERACCION ENTRE LA NEUROINFLAMACION, EL ESTRES OXIDATIVO Y...
182K€
Cerrado
SAF2016-79311-R
EFECTO DE LA NORMALIZACION DEL BALANCE REDOX SOBRE EL DESEQU...
129K€
Cerrado
SAF2010-20008
REGULACION DE LA SEÑALIZACION DE LA RESPUESTA ANTIOXIDANTE N...
363K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Alzheimer disease (AD) is the most common form of dementia among the elderly, whose care in Europe demands an amount of financial resources which is rising dramatically making AD a financial problem. Delaying AD onset by 5 years would decrease its prevalence by 50% with an enormous impact on the financial resources involved in AD care. Hence, it is necessary to understand the mechanisms related to the earlier phases before the symptoms onset. Insulin resistance is associated with a higher risk to develop AD. Post-mortem analysis of brains from AD subjects revealed a markedly downregulated expression of the insulin receptor (IR) and its downstream targets, which progresses with severity of neurodegeneration. Biliverdin reductase-A (BVR-A) is a pleiotropic enzyme that not only catalyzes the synthesis of the powerful antioxidant bilirubin but through its Ser/Thr/Tyr kinase activity modulates cell signaling networks including the two main arms of insulin signaling: MAPK and PI3K. Further, BVR-A is directly activated, via Tyr phosphorylation, by IR. Thus, being BVR-A an up-stream effector in the IR-mediated signaling cascade I hypothesize that the impairment of BVR-A activity contribute substantially to the progression of insulin resistance observed in AD, likely due to the oxidative damage as reported in the brain of aMCI and AD subjects. The aim of this project is to provide evidence about age-associated BVR-A-dependent changes of (i) oxidative/nitrosative stress levels; and (ii) the insulin-induced signaling pathways in 3xTg-AD mice model of AD. Finally, the effect of intranasal insulin (INI) administration, will be evaluated to describe age-dependent insulin effects on IR/BVR-A-dependent signaling pathways and cognition, to rule out if defects in insulin singling are associated with age-dependent changes of BVR-A expression and/or activity.